Entrevista a Javier Urcelay. Por Antonio Nieto

En enero Shire anunciaba la compra de Baxalta por 29.300 millones de euros, dando lugar a la una compañía líder global en el campo de las enfermedades raras. Su director general en España, Javier Urcelay, explica en qué posición se encuentra la compañía que, dice, espera lanzar 20 nuevos fármacos de aquí a 2020. Antonio Nieto entrevista al Director de Shire Pharmaceuticals Iberia, Javier Urcelay

Episode metadata supplied by the publisher feed · Published Mar 29, 2016

Embed this episode

Attribution link and audio player

Ready to play

Entrevista a Javier Urcelay. Por Antonio Nieto

0:00 12:44

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Saúde é o Tema Rádio Paulo Freire O podcast Saúde é o Tema é um programa semanal de entrevistas com profissionais de saúde e pesquisadores. A produção é da Rádio Paulo Freire.

Frequently Asked Questions

How long is this episode of Entrevistas NetSalud?

This episode is 12 minutes long.

When was this Entrevistas NetSalud episode published?

This episode was published on March 29, 2016.

Can I download this Entrevistas NetSalud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!